Abstract:Synthetic nanomaterials possessing biomolecular-chaperone functions are good candidates for modulating physicochemical interactions in many bioapplications. Despite extensive research, no general principle to engineer nanomaterial surfaces is available to precisely manipulate biomolecular conformations and behaviors, greatly limiting attempts to develop high-performance nanochaperone materials. Here, we demonstrate that, by quantifying the length (−SCxR±, x = 3–11) and charges (R– = −COO–, R+ = −NH3+) of ligands on Au25 gold nanochaperones (AuNCs), simulating binding sites and affinities of amyloid-like peptides with AuNCs, and probing peptide folding and fibrillation in the presence of AuNCs, it is possible to precisely manipulate the peptides' conformations and, thus, their amyloidosis via customizing AuNCs nanointerfaces. We show that intermediate-length liganded AuNCs with a specific charge chaperone peptides' native conformations and thus inhibit their fibrillation, while other types of AuNCs destabilize peptides and promote their fibrillation. We offer a microscopic molecular insight into peptide identity on AuNCs and provide a guideline in customizing nanochaperones via manipulating their nanointerfaces.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.nanolett.2c00149.Details of experimental methods, the characterization of AuNCs (including MS, UV–vis, XPS, FT-IR, CD spectra), the electrostatic energy (EELEC) of each amino acid of amylin or Aβ40 chain interacting with AuNCs by all-atom MD simulation, the adsorption result of natural or mutant Aβ40 peptides on SCxO2– (x = 3, 6, 11) by QCM, different doses of AuSCxR± on amylin and Aβ40 aggregation in vitro by ThT fluorescence assay, DLS, TEM, AFM, and CD spectra (PDF)This article has not yet been cited by other publications.

Efficient synthesis of longer Aβ peptides via removable backbone modification

Tuning Self-Assembled Morphology of the Aβ(16-22) Peptide by Substitution of Phenylalanine Residues.

Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization

Preparing synthetic Aβ in different aggregation states

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.

Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer's Disease Therapeutic Antibodies.

A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for biophysical and biological studies of Alzheimer's disease

Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer’s Disease Therapeutic Antibodies

Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

Longer Forms of Amyloid Β Protein: Implications for the Mechanism of Intramembrane Cleavage by Γ-Secretase

Probing into the interaction of β-amyloid peptides with bilayer lipid membrane by electrochemical techniques

Assembly of Nanoconjugates as New Kind Inhibitor of the Aggregation of Amyloid Peptides Associated with Alzheimer's Disease

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

Peptides of presenilin-1 bind the amyloid precursor protein ectodomain and offer a novel and specific therapeutic approach to reduce ß-amyloid in Alzheimer's disease

Amyloid-α Peptide Formed through Alternative Processing of the Amyloid Precursor Protein Attenuates Alzheimer's Amyloid-β Toxicity via Cross-Chaperoning

An 11-mer Synthetic Peptide Suppressing Aggregation of Aβ25-35 and Resolving Its Aggregated Form Improves Test Performance in an Aβ25-35-Induced Alzheimer's Mouse Model

Engineering Nanointerfaces of Au 25 Clusters for Chaperone-Mediated Peptide Amyloidosis

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization